SG Americas Securities
MGNX icon

SG Americas Securities’s MacroGenics MGNX Stock Holding History

SG Americas Securities’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,179
Closed -$29K – 3700
2025
Q3 		$29K Buy
17,179
+6,161
+56% +$9.97K ﹤0.01% 3253
2025
Q2 		$13K Sell
11,018
-29,422
-73% -$42.7K ﹤0.01% 2849
2025
Q1 		$51K Buy
40,440
+6,041
+18% +$15.8K ﹤0.01% 3241
2024
Q4 		$112K Buy
34,399
+17,577
+104% +$63.3K ﹤0.01% 2651
2024
Q3 		$55K Buy
+16,822
New +$65.5K ﹤0.01% 3227
2024
Q1 		– Sell
-28,589
Closed -$275K – 3246
2023
Q4 		$275K Buy
28,589
+7,712
+37% +$53.3K ﹤0.01% 1893
2023
Q3 		$97K Buy
+20,877
New +$104K ﹤0.01% 2801
2023
Q1 		– Sell
-27,635
Closed -$185K – 3441
2022
Q4 		$185K Sell
27,635
-3,856
-12% -$21.1K ﹤0.01% 2253
2022
Q3 		$109K Sell
31,491
-11,215
-26% -$42.9K ﹤0.01% 2801
2022
Q2 		$126K Buy
+42,706
New +$224K ﹤0.01% 2970
2022
Q1 		– Sell
-16,799
Closed -$270K – 3262
2021
Q4 		$270K Sell
16,799
-14,805
-47% -$279K ﹤0.01% 2500
2021
Q3 		$662K Buy
31,604
+23,146
+274% +$558K ﹤0.01% 2267
2021
Q2 		$227K Sell
8,458
-8,701
-51% -$255K ﹤0.01% 2278
2021
Q1 		$547K Sell
17,159
-584
-3% -$14.2K ﹤0.01% 1967
2020
Q4 		$406K Buy
17,743
+1,631
+10% +$37.6K ﹤0.01% 2143
2020
Q3 		$406K Sell
16,112
-7,881
-33% -$215K ﹤0.01% 1768
2020
Q2 		$670K Buy
23,993
+9,335
+64% +$162K 0.01% 1804
2020
Q1 		$85K Buy
+14,658
New +$133K ﹤0.01% 3059
2018
Q2 		– Sell
-4,717
Closed -$119K – 3467
2018
Q1 		$119K Buy
+4,717
New +$115K ﹤0.01% 2819
2017
Q4 		– Sell
-9,583
Closed -$177K – 3455
2017
Q3 		$177K Sell
9,583
-1,229
-11% -$21.3K ﹤0.01% 2693
2017
Q2 		$189K Buy
10,812
+5,187
+92% +$98.9K ﹤0.01% 2475
2017
Q1 		$105K Sell
5,625
-8,095
-59% -$156K ﹤0.01% 2962
2016
Q4 		$280K Buy
13,720
+6,262
+84% +$158K ﹤0.01% 2089
2016
Q3 		$223K Buy
+7,458
New +$222K ﹤0.01% 2409
2015
Q2 		– Sell
-62,322
Closed -$1.96M – 2741
2015
Q1 		$1.96M Buy
62,322
+58,728
+1,634% +$1.99M 0.01% 811
2014
Q4 		$126K Buy
+3,594
New +$89.6K ﹤0.01% 2767

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SG Americas Securities's MGNX Position: Q4 2025 in Review

SG Americas Securities sold out of MacroGenics (MGNX) in Q4 2025, closing a stake of 17,179 shares — an estimated $29K sold.

SG Americas Securities first reported a position in MGNX in Q4 2014 and held it in 26 quarters. The position peaked at $1.96M in Q1 2015. 88 funds tracked by Wall St. Rank hold MGNX as of Q4 2025.

  • SG Americas Securities reported no remaining MacroGenics position as of Q4 2025 after selling out during the quarter.
  • SG Americas Securities sold 17,179 MacroGenics shares in Q4 2025, an estimated $29K.
  • SG Americas Securities first reported a position in MacroGenics in Q4 2014 and held it in 26 quarters.
  • SG Americas Securities's MacroGenics position peaked at $1.96M in Q1 2015.
  • 88 funds tracked by Wall St. Rank held MacroGenics as of Q4 2025.

Based on SG Americas Securities's 13F filing for Q4 2025, filed 9 Jan 2026.